Abstract
According to classical definitions from the pre-antibiotic era, infective endocarditis (IE) was divided by the acuity of presenting symptoms and the rapidity of clinical evolution toward the anticipated lethal outcome. Patients with “acute” endocarditis had an abrupt onset and progression to death in less than six weeks. Patients with slowly developing symptoms were subdivided into categories of “subacute” or “chronic” endocarditis associated with a slowly progressing but also uniformly fatal illness lasting from several months to over two years [1]. The clinical features of acute endocarditis often included a hectic, rapidly deteriorating clinical course and dramatically invasive infection with destruction of heart valves and embolic complications early in the disease [2]. Before the introduction of echocardiography, about half of all IE cases were diagnosed only at autopsy [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Osler W. Malignant endocarditis. Lancet 1:415, 459, 505, 1885.
Bayer AS, Scheid WM. Endocarditis and intravascular infections. In Mandell, Bennett and Dolan (eds). Principles and Practice of Infectious Diseases, 5th edn, Churchill Livingstone, New York, 2000: 857.
Watanakunakorn C. Editorial response: Increasing importance of intravascular device-associated Staphylococcus aureus endocarditis. Clin Infect Dis 28:115, 1999.
Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, Levison M, Chambers HF, Dajani AS, Gewitz MH, New-burger JW, Gerber MA, Shulman ST, Pallasch TJ, Gage TW, Perrieri R. Diagnosis and management of infective endocarditis and its complications. Circulation 98:2936, 1998.
Durack DT, Kaplan EL, Bisno AL. Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry. JAMA 250:2318, 1983.
Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, Benjamin EJ. Prevalence and clinical outcome of mitral-valve prolapse. N Eng J Med 341:1, 1999.
Little JR, Murray PR, Traynor PS, Spitznagel E. A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: Effects on rates of blood culture contamination. Am J Med 107:119, 1999.
Bryant JK, Strand CL. Reliability of blood cultures collected from intravascular catheter versus venipuncture. Am J Clin Path 88:113, 1987.
Desjardin JA, Falagas ME, Ruthazer R, Griffith J, Wawrose D, Schenkein D, Miller K, Snydman DR. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med 131: 641, 1999.
Douglas JL, Dismukes WE. Surgical therapy of infective endocarditis on natural valves. In Kaye D (ed). Infective Endocarditis. Second edn, New York: Raven Press, 1992: 397.
Rosen AB, Fowler VG, Corey GR, Downs SM, Biddle AK, Li J, Jollis JG. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med 130:810, 1999.
Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infective endocarditis: An analysis based on strict case definitions. Ann Intern Med 94(part 1):505, 1981.
Durack DT, Lukes AS, Bright DK, the Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Am J Med 96:200, 1994.
Bayer AS, Ward JI, Glinzton LE, Shapiro SM. Evaluation of new clinical criteria for the diagnosis of infective endocarditis. Am J Med 96: 211, 1994.
Hoen B, Selton-Suty C, Danchin N, Weber M, Villemot J-P, Mathieu P, Floquet J, Canton P. Evaluation of the Duke criteria versus the Beth Israel criteria for the diagnosis of infective endocarditis. Clin Infect Dis 21:905, 1995.
Hoen B, Beguinot I, Raboud C, Jaussaud R, Selton-Suty C, May T, Canton P. The Duke criteria for diagnosing infective endocarditis are specific: analysis of 100 patients with acute fever or fever of unknown origin. Clin Infect Dis 23:298, 1996.
Heiro M, Nikoskelainen J, Hartiala JJ, Saraste JK, Kotilainen PM. Diagnosis of infective endocarditis: Sensitivity of the Duke vs von Reyn criteria. Arch Intern Med 158:18, 1998.
Dodds GA, Sexton DJ, Durack DT, Bashore TM, Corey GR, Kisslo J, the Duke Endocarditis Service. Negative predictive value of the Duke criteria for infective endocarditis. Am J Cardiol 77:403, 1996.
Nettles RE, McCarty DE, Corey GR, Li J, Sexton DJ. An evaluation of the Duke Criteria in 25 pathologically confirmed cases of prosthetic valve endocarditis. Clin Infect Dis 25:1401, 1997.
Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Relier LB. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584, 1997.
Karchmer AW. Staphylococcal endocarditis. In Kaye D (ed). Infective Endocarditis. Second Edn, Raven Press, 1992: 225.
Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit Medical Center. II infectious endocarditis: a prospective comparative study. Rev Infect Dis 8:374, 1986.
DiNubile MJ. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med 121:873, 1994.
Robbins MJ, Soeiro R, Frishman WH, Strom JA. Right-sided valvular endocarditis: etiology, diagnosis and an approach to therapy. Am Heart J 111:128, 1986.
Korzeniowski O, Sande MA, the National Collaborative Endocarditis Study Group. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts. Ann Intern Med 97:496, 1982.
Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms. JAMA 274:1706, 1995.
Scheid WM, Mandell GL. Enigmatic enterococcal endocarditis. Ann Int Med 100:904, 1984.
Hricak V, Kovacik J, Marx P, Fischer V, Krcmery V. Endocarditis due to Enterococcus faecal is: Risk factors and outcome in twenty-one cases from a five year national survey. Scand J Infect Dis 30:540, 1998.
Arthur M, Courvalin P. Genetics and mechanism of glycopeptide resistance in enterococci. Anti-microb Agents Chemotherap 37:1563, 1993.
Pfaller MA, Jones RN, Doern GV, Sader HS, Kugler KC, Beach ML. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 33:283, 1999.
Rice LB, Calderwood SB, Eliopoulos GM, Farber BF, Karchmer AW. Enterococcal endocarditis: A comparison of prosthetic and native valve disease. Rev Infect Dis 13:1, 1991.
Aronin SI, Mukherjee SK, West JC, Cooney EL. Review of pneumococcal endocarditis in adults in the penicillin era. Clin Infect Dis 26:165, 1998.
Ugolini V, Pacifico A, Smitherman TC, Mackowiak PA. Pneumococcal endocarditis update: analysis of 10 cases diagnosed between 1974 and 1984. Am Heart J 112:813, 1986.
Powderly WG, Stanley SL Jr, Medoff G. Pneumococcal endocarditis: report of a series and review of the literature. Rev Infect Dis 8:786, 1986.
Paris MM, Ramilo O, McCracken GH. Management of meningitis by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 39:2171, 1995.
Abusbeih G, Nickle HH. Meningococcal endocarditis due to dental caries in a previously healthy adult. Infect Dis Clin Practice 7:353, 1998.
Fijen CA, et al. Complement deficiencies in meningococcal infection. Clin Infect Dis 28:98, 1999.
Firestone GM. Meningococcus endocarditis. Am J Med Sei 211:556, 1946.
Wall TC, Peyton RB, Corey GR. Gonococcal endocarditis: A new look at an old disease. Medicine 68:375, 1989.
Jackman JD, Glamann DB. Gonococcal endocarditis: twenty five-year experience. Am J Med Sci 301:221, 1991.
Sobel JL, Maisel AS, Tarazi R, Blanchard DG. Gonococcal endocarditis: assessment by transesophageal echocardiography. J Am Soc Echocardiog 10:367, 1997.
Black JR, Brint JM, Reichart CA. Successful treatment of gonococcal endocarditis with ceftriaxone. J Infect Dis 157:1281, 1988.
Savage D, Brown J. Endocarditis due to group A streptococcus. Am J Med Sci 282:98, 1981.
Barg NL, Kish MA, Kauffman CA, Supena RB. Group A streptococcal bacteremia in intravenous drug abusers. Am J Med 78:569, 1985.
Burkert T, Watanakunakorn C. Group A streptococcus endocarditis: report of five cases and review of the literature. J Infect 23:307, 1991.
Baddour LM and the Infectious Diseases Society of America’s Emerging Infections Network. Infective endocarditis caused by β-hemolytic streptococci. Clin Infect Dis 26:66, 1997.
Gallagher PG, Watanakunakorn C. Group B streptococcal endocarditis: Report of seven cases and review of the literature, 1962–1985. Rev Infect Dis 8:175, 1986.
Fernandez-Guerrero ML, Verdejo JA, de Gorgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis 20:16, 1995.
Chen S, Dwyer DE, Sorrell TC. A comparison of hospital and community-acquired infective endocarditis. Am J Cardiol 70:1449, 1992.
Fowler VG, Li J, Corey GR, Boley J, Marr KA, Gopal AK, Kong K, Gottlieb G, Donovan CL, Sexton DJ, Ryan T. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: Experience with 103 patients. J Am Coll Cardiol 30:1072, 1997.
Lamas CC, Eykyn S. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: Analysis of 118 pathologically proven cases. Clin Inf Dis 25:713, 1997.
Calderwood SB, Swinski LA, Waternaux CM, Karchmer AW, Buckley MJ. Risk factors for the development of prosthetic valve endocarditis. Circulation 72:31, 1985.
Karchmer AW. In Korzeniowski OM (ed). Atlas of Infectious Diseases. Vol 10, Cardiovascular Infections, Philadelphia, PA: Current Medicine, 1998: 5.2.
Fisher EA, Fisher LL, Fuster V, Goldman ME. Infective endocarditis: New perspectives on an old disease. Infect Dis Clin Practice 7:12, 1998.
Chastre J, Trouillet JL. Early infective endocarditis on prosthetic valves. Eur Heart J 16: (suppl B):32, 1995.
Wolf M, Witchitz S, Chastang C, Regnier B, Vaschon F. Prosthetic valve endocarditis in the ICU; prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision. Chest 108:688, 1995.
Yu VL, Fang GD, Keys TF, Harris AA, Gentry LO, Fuchs PC, Wagener MM, Wong ES. Prosthetic valve endocarditis: Superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg 58:1073. Vongpatanasin W, Hillis L, Lange RA. Prosthetic heart valves. N Eng J Med 335:407, 1996.
Vlessis AA, Hovaguimian H, Jagges J, Ahmad A, Starr A. Infective endocarditis: Ten year review of medical and surgical therapy. Ann Thorac Surg 61:1217, 1996.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sanchez, J.L., Little, R. (2001). Acute Infective Endocarditis. In: Rello, J., Valles, J., Kollef, M.H. (eds) Critical Care Infectious Diseases Textbook. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1679-8_25
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1679-8_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5674-5
Online ISBN: 978-1-4615-1679-8
eBook Packages: Springer Book Archive